Literature DB >> 26565954

Primary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancer.

Linghua Chen1, Xiaoyan Zhang2.   

Abstract

AIMS: Immunotherapy is an important treatment for pancreatic cancer (PC) patients. To evaluate the therapeutic efficacy of immunotherapy in the treatment of PC, we performed a systemic review and meta-analysis of the relevant published clinical trials, collectively referred to as DC, DC-CIK, LAK, NK and GM-CSF secreting PC cell lines. MATERIALS &
METHODS: A total of 413 patients in 11 eligible trials with PC were selected for the present meta-analysis.
RESULTS: The estimated pooled overall survival showed a significant improvement for PC patients who received immunotherapy compared with nonimmunotherapy. The lymphocyte subsets, immune cytokine levels and serum cancer markers in the peripheral blood of PC patients were significantly improved after immunotherapy.
CONCLUSION: The results showed that immunotherapy can improve the efficacy of the treatment of PC patients.

Entities:  

Keywords:  cytokine-induced killer cells; dendritic cells; immunotherapy; lymphokine-activated killer cells; meta-analysis; natural killer cells; pancreatic cancer

Mesh:

Substances:

Year:  2015        PMID: 26565954     DOI: 10.2217/imt.15.105

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  8 in total

1.  Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.

Authors:  Li Xiao; Ulrike Erb; Kun Zhao; Thilo Hackert; Margot Zöller
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

Review 2.  The pancreatic cancer microenvironment: A true double agent.

Authors:  Laleh G Melstrom; Marcela D Salazar; Don J Diamond
Journal:  J Surg Oncol       Date:  2017-06-12       Impact factor: 3.454

Review 3.  Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Jiang Chen; Guo Xiao-Zhong; Xing-Shun Qi
Journal:  J Immunol Res       Date:  2017-02-07       Impact factor: 4.818

4.  Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis.

Authors:  Xiuling Zhou; Xiangqiong Mo; Junlan Qiu; Jingjing Zhao; Shuncong Wang; Cuiling Zhou; Yonghui Su; Zhong Lin; Haiqing Ma
Journal:  Cancer Manag Res       Date:  2018-11-05       Impact factor: 3.989

5.  T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.

Authors:  Can Cui; Xiuyun Tian; Jianhui Wu; Chaoting Zhang; Qin Tan; Xiaoya Guan; Bin Dong; Min Zhao; Zheming Lu; Chunyi Hao
Journal:  Cancer Sci       Date:  2018-12-21       Impact factor: 6.716

Review 6.  Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.

Authors:  Francesca Garofano; Maria A Gonzalez-Carmona; Dirk Skowasch; Roland Schmidt-Wolf; Alina Abramian; Stefan Hauser; Christian P Strassburg; Ingo G H Schmidt-Wolf
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

7.  Analysis of T-cell receptor repertoire in peripheral blood of patients with pancreatic cancer and other pancreatic diseases.

Authors:  Hui Wang; Yue Yuan; Chenglin Lu; Siqi Zhou; Yixuan Zhang; Jing Zhao; Chenghu Xu; Jie Yang; Haochen Su; Borui Li; Xihan Li; Pin Wang; Guifang Xu; Lei Wang; Xiaoping Zou; Shanhua Bao; Shu Zhang; Ying Lv
Journal:  J Cell Mol Med       Date:  2021-03-08       Impact factor: 5.310

8.  Clinical applications of dendritic cells-cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis.

Authors:  Yucai Zhang; Xiaorui Zhang; Anqi Zhang; Ke Li; Kai Qu
Journal:  Onco Targets Ther       Date:  2017-08-23       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.